CAMCEVI
Active substance: leuprolide
INJECTION, EMULSION · LEUPROLIDE MESYLATE 42 mg/.37g
United StatesActive
Marketing holder: Accord BioPharma, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- LEUPROLIDE MESYLATE · 42 mg/.37g
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-4655-7172-a620-09f84ae79abf,01a1208c-46b9-7d4d-94d3-a8201dd51759,01a1208c-8b73-7d2f-8510-fe35987b644f,01a1208d-14da-760f-9d2e-558c82e8ef93,01a1208d-63ae-712e-9f25-3b6697304cf3;count=42 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 69448-023
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 69448-023 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 69448-023 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 69448-023 · Verified 2026-10-09 · open in source